- Email: [email protected]
Abstract list
Critical Reviews in Oncology/Hematology 82 S1 (2012) S34−S35
Abstract list IN1 IN2 IN3 IN4 IN5 IN6 IN7 IN8 IN9 IN10 IN11 IN12 IN13 IN14 IN15 IN16 IN17 OR18 OR19 OR20 OR21 PO22 PO23 PO24 PO25 PO27 PR28 OR29 OR30 OR31 OR32 OR33 OR34 PO35 PO36 PO37 PO38 PO39 PO40 PO41 PO42 PO43 PO44
Molecular biology of AML Therapeutic strategies of AML From biology to therapy in chronic lymphocytic leukaemia Chronic myeloid leukemia What’s new in myelodysplastic syndromes? Moving forward a more cost-effective therapy of Hodgkin’s lymphoma PET: staging, response assessment and open questions Radiotherapy in non-Hodgkin’s lymphomas Pathology and pathophysiology of peripheral T-cell lymphomas Primary mediastinal B-cell lymphoma Current treatment landscape in myelofibrosis Marginal zone lymphomas Follicular lymphoma Diffuse large B-cell lymphoma (DLBCL) Primary CNS lymphoma New drugs for the treatment of lymphomas Survival impact of prophylactic administration of darbepoetin alfa in patients with diffuse large B-cell lymphoma treated with immunochemotherapy: the LNH03-6B study T-ALL: CNS secondary involvement or meningoencephalitis? Lenalidomide: a valid therapeutic option in primary myelofibrosis (PMF) Lenalidomide in 5q− syndrome? An efficient therapeutic option Hodgkin’s lymphoma transforming into T-cell acute lymphoblastic leukemia Honey reduces chemoradiotherapy-induced mucositis in pediatric cancer patients Health and quality of life outcomes in patient with sickle cell disease The prevalence of the most common causes for primary thrombophilia among Saudi patients attending the anticoagulant clinic Clinico-pathologic factors affecting short term mortality in paediatric and adolescent ALL patients Hematologic and cytogenetic response to imatinib mesylate in chronic myeloid leukemia Insurance coverage and haematological malignancies. A study from India Hemophagocytic lymphohistiocytosis in transplanted Hodgkin’s lymphoma Eosinophilic granuloma? A rare case Treatment of brain lymphoma in a patient with unfit general condition Procarbazine’s role in symptoms control of DLBCL with SNC involvement, a case report Secondary pancreatic involvement by diffuse large B-cell lymphoma presenting as acute pancreatitis Double-hit non-Hodgkin’s lymphoma − therapeutic problem Total skin electron beam radiation therapy in cutaneous T-cell lymphoma − a retrospective experience B-cell non-Hodgkin’s lymphoma of small lymphocytes Rituximab maintenance therapy in diffuse large B-cell lymphoma Re-treatment versus rituximab maintenance therapy at progression in patients with follicular lymphoma Long-term survival after histologic transformation from high grade B cell non-Hodgkin’s lymphoma to low grade follicular lymphoma and Hodgkin’s disease in the same patient Bacterial contamination of platelets for transfusion in transplanted lymphoma patients Rapidly progressive transformed follicular lymphoma, a case report Non-Hodgkin’s lymphoma of bone Hodgkin’s lymphoma as Richter transformation in chronic lymphocytic leukaemia Primary bone marrow diffuse large B cell lymphoma: a case report
Abstract list / Critical Reviews in Oncology/Hematology 82 S1 (2012) S34−S35
S35
PO45 A case of primary cardiac lymphoma with systemic involvement PO46 Sustained remission after mTOR inhibitor in a case of refractory HD PO47 The introduction of immunohistochemistry for the diagnosis of lymphomas at the Pathology Department of the National Institute of Oncology, Cuba PR49 Stressful life events and psychopathology in the pathogenesis of non-Hodgkin’s lymphoma (NHL) PR50 Quality of life (QoL) in patients with non-Hodgkin’s lymphoma (NHL) after psychosocial rehabilitation PR51 Sleep disturbances and depression in patients with non-Hodgkin’s lymphoma (NHL) PR52 The value of dual point interim FDG-PET/CT assessment in a patient with advanced Hodgkin’s lymphoma (HL) with bulky masses treated with ABVD chemotherapy PR53 Tolerability of metronomic chemotherapy in patients with haematological malignancies. A study from India OR54 Cutaneous plasmacytomas in a patient with refractory nonsecretory myeloma OR55 Nonsecretory multiple myeloma presenting with extensive extramedullary plasmacytoma OR56 The differential diagnosis: multiple myeloma or Waldenstr¨om’s macroglobulinemia? OR57 Coincidence of multiple myeloma and non-Hodgkin’s lymphoma in female
Abstract list IN1 IN2 IN3 IN4 IN5 IN6 IN7 IN8 IN9 IN10 IN11 IN12 IN13 IN14 IN15 IN16 IN17 OR18 OR19 OR20 OR21 PO22 PO23 PO24 PO25 PO27 PR28 OR29 OR30 OR31 OR32 OR33 OR34 PO35 PO36 PO37 PO38 PO39 PO40 PO41 PO42 PO43 PO44
Molecular biology of AML Therapeutic strategies of AML From biology to therapy in chronic lymphocytic leukaemia Chronic myeloid leukemia What’s new in myelodysplastic syndromes? Moving forward a more cost-effective therapy of Hodgkin’s lymphoma PET: staging, response assessment and open questions Radiotherapy in non-Hodgkin’s lymphomas Pathology and pathophysiology of peripheral T-cell lymphomas Primary mediastinal B-cell lymphoma Current treatment landscape in myelofibrosis Marginal zone lymphomas Follicular lymphoma Diffuse large B-cell lymphoma (DLBCL) Primary CNS lymphoma New drugs for the treatment of lymphomas Survival impact of prophylactic administration of darbepoetin alfa in patients with diffuse large B-cell lymphoma treated with immunochemotherapy: the LNH03-6B study T-ALL: CNS secondary involvement or meningoencephalitis? Lenalidomide: a valid therapeutic option in primary myelofibrosis (PMF) Lenalidomide in 5q− syndrome? An efficient therapeutic option Hodgkin’s lymphoma transforming into T-cell acute lymphoblastic leukemia Honey reduces chemoradiotherapy-induced mucositis in pediatric cancer patients Health and quality of life outcomes in patient with sickle cell disease The prevalence of the most common causes for primary thrombophilia among Saudi patients attending the anticoagulant clinic Clinico-pathologic factors affecting short term mortality in paediatric and adolescent ALL patients Hematologic and cytogenetic response to imatinib mesylate in chronic myeloid leukemia Insurance coverage and haematological malignancies. A study from India Hemophagocytic lymphohistiocytosis in transplanted Hodgkin’s lymphoma Eosinophilic granuloma? A rare case Treatment of brain lymphoma in a patient with unfit general condition Procarbazine’s role in symptoms control of DLBCL with SNC involvement, a case report Secondary pancreatic involvement by diffuse large B-cell lymphoma presenting as acute pancreatitis Double-hit non-Hodgkin’s lymphoma − therapeutic problem Total skin electron beam radiation therapy in cutaneous T-cell lymphoma − a retrospective experience B-cell non-Hodgkin’s lymphoma of small lymphocytes Rituximab maintenance therapy in diffuse large B-cell lymphoma Re-treatment versus rituximab maintenance therapy at progression in patients with follicular lymphoma Long-term survival after histologic transformation from high grade B cell non-Hodgkin’s lymphoma to low grade follicular lymphoma and Hodgkin’s disease in the same patient Bacterial contamination of platelets for transfusion in transplanted lymphoma patients Rapidly progressive transformed follicular lymphoma, a case report Non-Hodgkin’s lymphoma of bone Hodgkin’s lymphoma as Richter transformation in chronic lymphocytic leukaemia Primary bone marrow diffuse large B cell lymphoma: a case report
Abstract list / Critical Reviews in Oncology/Hematology 82 S1 (2012) S34−S35
S35
PO45 A case of primary cardiac lymphoma with systemic involvement PO46 Sustained remission after mTOR inhibitor in a case of refractory HD PO47 The introduction of immunohistochemistry for the diagnosis of lymphomas at the Pathology Department of the National Institute of Oncology, Cuba PR49 Stressful life events and psychopathology in the pathogenesis of non-Hodgkin’s lymphoma (NHL) PR50 Quality of life (QoL) in patients with non-Hodgkin’s lymphoma (NHL) after psychosocial rehabilitation PR51 Sleep disturbances and depression in patients with non-Hodgkin’s lymphoma (NHL) PR52 The value of dual point interim FDG-PET/CT assessment in a patient with advanced Hodgkin’s lymphoma (HL) with bulky masses treated with ABVD chemotherapy PR53 Tolerability of metronomic chemotherapy in patients with haematological malignancies. A study from India OR54 Cutaneous plasmacytomas in a patient with refractory nonsecretory myeloma OR55 Nonsecretory multiple myeloma presenting with extensive extramedullary plasmacytoma OR56 The differential diagnosis: multiple myeloma or Waldenstr¨om’s macroglobulinemia? OR57 Coincidence of multiple myeloma and non-Hodgkin’s lymphoma in female